Handok Inc. director buys Rezolute shares worth $17 million By Investing.com
© Reuters. Handok Inc., a major shareholder and director in Rezolute , Inc. (NASDAQ:), has made significant stock purchases in
Read More© Reuters. Handok Inc., a major shareholder and director in Rezolute , Inc. (NASDAQ:), has made significant stock purchases in
Read More© Reuters. Mirum Pharmaceuticals, Inc. (NASDAQ:) has reported a recent transaction involving the company’s President and Chief Operating Officer, Peter
Read MoreThe department of pharmaceutical (DoP) has formed a five-member committee to review the pricing framework for drugs and medical devices.
Read MoreWhile President Joe Biden is using Medicare to lower the cost of a handful of overpriced drugs and wants to
Read MoreDespite increasing investments in AI for drug discovery, the report mentions that no novel active substances have yet been brought
Read MoreAlexandria Real Estate Equities (ARE) executive chairman & founder Joel S. Marcus, joined by Whitney Snider, MD, vice president of
Read MoreRepresentational file image. | Photo Credit: AFP The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP)
Read MoreLawmakers from both parties and thirty-nine state attorneys general joined forces to stop the shadowy corporate middlemen behind rising drug
Read MoreAs the government begins its first-ever price negotiations for a handful of medicines under Medicare, the pharmaceutical industry has launched
Read MoreAs the Biden administration launches a long-awaited fight to lower prices of lifesaving drugs developed with public funding, a formidable
Read More